Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 3 Prostatic Neoplasms 3 Stomach Neoplasms 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Thrombosis 1 Stroke 1 Skin Neoplasms 1 Sarcoma, Kaposi 1 Rhabdomyosarcoma 1 Resectable Pancreatic Carcinoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nevus, Pigmented 1 Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Glioma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 34 pembrolizumab 26 Paclitaxel 21 Cyclophosphamide 21 Docetaxel 20 Carboplatin 20 Irinotecan 19 Capecitabine 19 Fluorouracil 17 Bevacizumab 15 Dexamethasone 14 fludarabine 13 Oxaliplatin 13 Leucovorin 13 Blood Specimen Collection 13 Everolimus 12 Cetuximab 12 Ipilimumab 11 Erlotinib Hydrochloride 11 Rituximab 10 Pemetrexed 10 Cisplatin 10 venetoclax 9 Temozolomide 9 Sunitinib 9 Nivolumab 9 Trastuzumab 8 Interleukin-2 8 aldesleukin 7 Epoetin Alfa 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × X-Rays × Clear all

NCT02207959 2017-05-02

Gastric In Vivo Study

Icahn School of Medicine at Mount Sinai

Phase 1 Terminated

Gastrointestinal

Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡